Allogenic Mesenchymal Stromal Cells therapy

N/A

Report date: 2023/11/01 20:08:59

Base Information

Drug NameAllogenic Mesenchymal Stromal Cells therapy
Drug Alias NameMesenchymal Stromal Cells (MSCs)Transplantation of MSCs therapyAllogeneic MSCs therapyMSCs therapyAllogenic mesenchymal stromal cells form bone marrow (BM-MSC) or adipose tissue(Ad-MSC)
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived +[4] 
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsFractures, UnunitedBurnsJoint Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesVenezuela
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInstituto Venezolano De Investigaciones Cientificas
China Registration ClassN/A

Develop Information

Active CompaniesInstituto Venezolano De Investigaciones CientificasIo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsFractures, UnunitedBurnsJoint Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A